{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:07:44Z","timestamp":1790168864021,"version":"4.1.0"},"reference-count":85,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.3201\/eid2207.160022","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T15:58:16Z","timestamp":1463587096000},"source":"Crossref","is-referenced-by-count":19,"title":["Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus"],"prefix":"10.3201","volume":"22","author":[{"given":"Timothy M.","family":"Uyeki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Erlandson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Korch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Hu-Primmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Hojvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Stemmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armen","family":"Donabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2207.160022-201607140919-R1","unstructured":"World Health Organization. Emergencies preparedness, response: Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014Saudi Arabia. 2016 Apr 27 [cited 2016 Apr 27]. http:\/\/www.who.int\/csr\/don\/26-april-2016-mers-saudi-arabia\/en\/"},{"key":"key-10.3201\/eid2207.160022-201607140919-R2","unstructured":"World Health Organization. Summary of current situation, literature update and risk assessment [updated 2015 July 7; cited 2015 Aug 12]. http:\/\/apps.who.int\/\/iris\/bitstream\/10665\/179184\/2\/WHO_MERS_RA_15.1_eng.pdf"},{"key":"key-10.3201\/eid2207.160022-201607140919-R3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1306742","article-title":"Hospital outbreak of Middle East respiratory syndrome coronavirus.","volume":"369","author":"Assiri","year":"2013","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJMoa1408636","article-title":"2014 MERS-CoV outbreak in Jeddah\u2014a link to health care facilities.","volume":"372","author":"Oboho","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3201\/eid2201.151340","article-title":"Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014.","volume":"22","author":"Alraddadi","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R6","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/civ1020","article-title":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea.","volume":"62","author":"Bin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R7","first-page":"431","article-title":"First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities\u2014May 2014.","volume":"63","author":"Bialek","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2207.160022-201607140919-R8","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/cid\/ciu635","article-title":"Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States.","volume":"59","author":"Kapoor","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R9","doi-asserted-by":"crossref","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014Republic of Korea. 2015 Jul 21 [cited 2016 Jan 5]. http:\/\/www.who.int\/csr\/don\/21-july-2015-mers-korea\/en\/","DOI":"10.6118\/jmm.2015.21.2.63"},{"key":"key-10.3201\/eid2207.160022-201607140919-R10","unstructured":"World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014China. 2015 May 30 [cited 2015 Dec 21]. http:\/\/www.who.int\/csr\/don\/30-may-2015-mers-china\/en\/"},{"key":"key-10.3201\/eid2207.160022-201607140919-R11","unstructured":"National Institutes of Health. Middle East respiratory syndrome coronavirus (MERS-CoV) research: current status and future priorities. 2013 Jun 24 [cited 2015 Dec 1]. http:\/\/www.niaid.nih.gov\/about\/organization\/dmid\/documents\/mers-covmeeting.pdf"},{"key":"key-10.3201\/eid2207.160022-201607140919-R12","unstructured":"National Academies of Sciences, Engineering, and Medicine. 2016. Rapid medical countermeasure response to infectious diseases: enabling sustainable capabilities through ongoing public and private-sector partnerships. Workshop summary [cited 2016 Mar 17]. http:\/\/www.nap.edu\/read\/21809\/chapter\/1"},{"key":"key-10.3201\/eid2207.160022-201607140919-R13","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome.","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R14","unstructured":"Agrawal AS, Garron T, Tao X, Peng B-H, Wakamiya M, Chan T-S, Generation of transgenic mouse model of Middle East respiratory syndrome-coronavirus infection and disease. J Virol. 2015 Jan 14;JVI.03427\u201314. 25589660"},{"key":"key-10.3201\/eid2207.160022-201607140919-R15","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against spike protein in a novel humanized mouse model of MERS-CoV infection.","volume":"213","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R16","doi-asserted-by":"crossref","unstructured":"Houser KV, Gretebeck L, Ying T, Wang Y, Vogel L, Lamirande EW, Prophylaxis with a Middle East respiratory syndrome coronavirus (MERS-CoV)\u2013specific human monoclonal antibody protects rabbits from MERS-CoV infection. J Infect Dis. Epub 2016 Mar 3.","DOI":"10.1093\/infdis\/jiw080"},{"key":"key-10.3201\/eid2207.160022-201607140919-R17","doi-asserted-by":"publisher","first-page":"16598","DOI":"10.1073\/pnas.1310744110","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.","volume":"110","author":"de Wit","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R18","doi-asserted-by":"publisher","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset.","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog"},{"key":"key-10.3201\/eid2207.160022-201607140919-R19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.3201\/eid2012.141280","article-title":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels.","volume":"20","author":"Adney","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R20","doi-asserted-by":"crossref","unstructured":"Gretebeck LM, Subbarao K. Animal models for SARS and MERS coronaviruses. Curr Opin Virol. 2015;13:123\u20139.","DOI":"10.1016\/j.coviro.2015.06.009"},{"key":"key-10.3201\/eid2207.160022-201607140919-R21","doi-asserted-by":"crossref","unstructured":"Baseler L, de Wit E, Feldmann H. A comparative review of animal models of Middle East respiratory syndrome coronavirus infection. Vet Pathol. Epub 2016 Feb 11. 26869154","DOI":"10.1177\/0300985815620845"},{"key":"key-10.3201\/eid2207.160022-201607140919-R22","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against spike protein in a novel humanized mouse model of MERS-CoV infection.","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection.","volume":"22","author":"van Doremalen","year":"2015","journal-title":"Antiviral Res"},{"key":"key-10.3201\/eid2207.160022-201607140919-R24","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset.","volume":"212","author":"Chan","year":"2015","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R25","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.virol.2015.07.013","article-title":"Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3\/2012 or MERS-CoV EMC\/2012 isolates does not result in lethal disease.","volume":"485","author":"Johnson","year":"2015","journal-title":"Virology"},{"key":"key-10.3201\/eid2207.160022-201607140919-R26","doi-asserted-by":"crossref","unstructured":"Adney D, Bielefeldt-Ohmann H, Hartwig A, Bowen RA. Infection, replication, and transmission of Middle East respiratory syndrome coronavirus in alpacas. Emerg Infect Dis. 2016 Jun. Epub 2016 Mar 4.","DOI":"10.3201\/eid2206.160192"},{"key":"key-10.3201\/eid2207.160022-201607140919-R27","doi-asserted-by":"crossref","unstructured":"Crameri G, Durr PA, Klein R, Foord A, Yu M, Riddell S. Experimental infection and response to rechallenge of alpacas with Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016 Jun. Epub 2016 Mar 7.","DOI":"10.3201\/eid2206.160007"},{"key":"key-10.3201\/eid2207.160022-201607140919-R28","doi-asserted-by":"crossref","unstructured":"Reusken CBEM, Schilp C, Raj VS, De Bruin E, Kohl RHG, Farag EABA, MERS-CoV infection of alpaca in a region where MERS-CoV is endemic [letter]. Emerg Infect Dis. 2016 Jun. Epub 2016 Feb 16.","DOI":"10.3201\/eid2206.152113"},{"key":"key-10.3201\/eid2207.160022-201607140919-R29","doi-asserted-by":"crossref","unstructured":"Song JY, Cheong HJ, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Viral shedding and environmental cleaning in Middle East respiratory syndrome coronavirus infection. Infect Chemother. 2015;47:252\u20135.","DOI":"10.3947\/ic.2015.47.4.252"},{"key":"key-10.3201\/eid2207.160022-201607140919-R30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijid.2014.10.002","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) viral shedding in the respiratory tract: an observational analysis with infection control implications.","volume":"29","author":"Memish","year":"2014","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R31","unstructured":"Office of the Commissioner. MCM Legal, Regulatory and Policy Framework\u2014Emergency Use Authorization; Middle East respiratory syndrome coronavirus (MERS-VoV) EUS information [cited 2015 Oct 1]. http:\/\/www.fda.gov\/EmergencyPreparedness\/Counterterrorism\/MedicalCountermeasures\/MCMLegalRegulatoryandPolicyFramework\/ucm182568.htm#MERS"},{"key":"key-10.3201\/eid2207.160022-201607140919-R32","doi-asserted-by":"crossref","first-page":"20334","DOI":"10.2807\/ese.17.49.20334-en","article-title":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections.","volume":"17","author":"Corman","year":"2012","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid2207.160022-201607140919-R33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jcv.2015.05.022","article-title":"First international external quality assessment of molecular diagnostics for Mers-CoV.","volume":"69","author":"Pas","year":"2015","journal-title":"J Clin Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R34","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2207.160022-201607140919-R35","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2207.160022-201607140919-R36","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV\u2013infected rhesus macaques.","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study.","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R39","unstructured":"European Medicines Agency. Public summary of opinion on orphan designation. Interferon alfa-n3 for the treatment of Middle East respiratory syndrome. 5 Jan 2016 [cited 2016 Mar 17]. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Orphan_designation\/2016\/01\/WC500199406.pdf"},{"key":"key-10.3201\/eid2207.160022-201607140919-R40","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: Systematic review of treatment effects.","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"key-10.3201\/eid2207.160022-201607140919-R42","unstructured":"Adedeji AO, Singh K, Kassim A, Coleman CM, Elliott R, Weiss SR, Evaluation of SSYA10\u2013001 as a replication inhibitor of SARS, MHV and MERS coronaviruses. Antimicrob Agents Chemother. Epub 2014 May 19 [cited 2014 May 22]. http:\/\/aac.asm.org\/cgi\/doi\/10.1128\/AAC.02994-14"},{"key":"key-10.3201\/eid2207.160022-201607140919-R43","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/pbi.12441","article-title":"Anti-infective immunoadhesins from plants.","volume":"13","author":"Wycoff","year":"2015","journal-title":"Plant Biotechnol J"},{"key":"key-10.3201\/eid2207.160022-201607140919-R44","doi-asserted-by":"crossref","unstructured":"Channappanavar R, Lu L, Xia S, Du L, Meyerholz DK, Perlman S, Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection. J Infect Dis. 2015;212:1894\u2013903.10.1093\/infdis\/jiv325","DOI":"10.1093\/infdis\/jiv325"},{"key":"key-10.3201\/eid2207.160022-201607140919-R45","doi-asserted-by":"publisher","first-page":"11955","DOI":"10.1128\/JVI.02105-13","article-title":"Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors.","volume":"87","author":"Kilianski","year":"2013","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R46","unstructured":"ClinicalTrials.gov. Anti\u2013MERS-COV convalescent plasma therapy [cited 2015 Aug 11]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02190799"},{"key":"key-10.3201\/eid2207.160022-201607140919-R47","unstructured":"Shultz D. Cows with human chromosomes enlisted to fight hantavirus. Science. Epub 2014 Nov 25 [cited 2015 Aug 11. http:\/\/news.sciencemag.org\/biology\/2014\/11\/cows-human-chromosomes-enlisted-fight-hantavirus"},{"key":"key-10.3201\/eid2207.160022-201607140919-R48","doi-asserted-by":"publisher","first-page":"7798","DOI":"10.1128\/JVI.00912-14","article-title":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.","volume":"88","author":"Ying","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R49","doi-asserted-by":"crossref","unstructured":"Jiang L, Wang N, Zuo T, Shi X, Poon KMV, Wu Y, Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med. 2014;6:234ra59. 24778414","DOI":"10.1126\/scitranslmed.3008140"},{"key":"key-10.3201\/eid2207.160022-201607140919-R50","doi-asserted-by":"publisher","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution.","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R51","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1128\/JVI.00433-14","article-title":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in MERS-CoV spike protein.","volume":"88","author":"Du","year":"2014","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R52","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1128\/JVI.02448-13","article-title":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody.","volume":"87","author":"Ohnuma","year":"2013","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R53","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid2207.160022-201607140919-R54","doi-asserted-by":"crossref","unstructured":"Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen KY. Coronaviruses\u2014drug discovery and therapeutic options. Nat Rev Drug Discov. Epub 2016 Feb 12.","DOI":"10.1038\/nrd.2015.37"},{"key":"key-10.3201\/eid2207.160022-201607140919-R55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2016.01.004","article-title":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3\/2012.","volume":"490","author":"Johnson","year":"2016","journal-title":"Virology"},{"key":"key-10.3201\/eid2207.160022-201607140919-R56","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.micinf.2014.11.008","article-title":"Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.","volume":"17","author":"Ying","year":"2015","journal-title":"Microbes Infect"},{"key":"key-10.3201\/eid2207.160022-201607140919-R57","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo.","volume":"8","author":"Luke","year":"2016","journal-title":"Sci Transl Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection.","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid2207.160022-201607140919-R59","doi-asserted-by":"crossref","unstructured":"Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712.","DOI":"10.1038\/ncomms8712"},{"key":"key-10.3201\/eid2207.160022-201607140919-R60","doi-asserted-by":"crossref","unstructured":"Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7:301ra132. 26290414","DOI":"10.1126\/scitranslmed.aac7462"},{"key":"key-10.3201\/eid2207.160022-201607140919-R61","unstructured":"Clinical Trials.gov. Phase I, open label dose ranging safety study of GLS-5300 in healthy volunteers [cited 2016 Mar 17]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02670187?term=mers-cov&rank=7"},{"key":"key-10.3201\/eid2207.160022-201607140919-R62","unstructured":"Greffex, Inc. MERS [cited 2015 Oct 1]. http:\/\/www.greffex.com\/vaccines\/mers\/"},{"key":"key-10.3201\/eid2207.160022-201607140919-R63","doi-asserted-by":"publisher","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.","volume":"87","author":"Song","year":"2013","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R64","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein.","volume":"89","author":"Volz","year":"2015","journal-title":"J Virol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R65","doi-asserted-by":"crossref","unstructured":"Wang L, Shi W, Joyce MG, Modjarrad K, Zhang Y, Leung K, Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712.","DOI":"10.1038\/ncomms8712"},{"key":"key-10.3201\/eid2207.160022-201607140919-R66","doi-asserted-by":"crossref","unstructured":"Almazan F, DeDiego ML, Sola I, Zuniga S, Nieto-Torres JL, Marquez-Jurado S, Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBiol 2013;4:e00650-13. 24023385","DOI":"10.1128\/mBio.00650-13"},{"key":"key-10.3201\/eid2207.160022-201607140919-R67","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/cmi.2015.03","article-title":"Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.","volume":"13","author":"Zhang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R68","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/infdis\/jit609","article-title":"Evaluation of serologic and antigenic relationships between Middle Eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.","volume":"209","author":"Agnihothram","year":"2014","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R69","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2207.160022-201607140919-R70","unstructured":"Dodge J. Camels emit dangerous MERS virus, CSU confirms. November 2014 [cited 2015 Oct 2]. http:\/\/source.colostate.edu\/camels-emit-mers\/"},{"key":"key-10.3201\/eid2207.160022-201607140919-R71","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1126\/science.347.6228.1296","article-title":"MERS surges again, but pandemic jitters ease.","volume":"347","author":"Kupferschmidt","year":"2015","journal-title":"Science"},{"key":"key-10.3201\/eid2207.160022-201607140919-R72","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East respiratory syndrome coronavirus vaccine in BALB\/c mice.","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2207.160022-201607140919-R73","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3201\/eid2107.150070","article-title":"MERS-CoV in upper respiratory tract and lungs of dromedary camels, Saudi Arabia, 2013\u20132014.","volume":"21","author":"Khalafalla","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R74","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3201\/eid2007.140571","article-title":"MERS coronavirus in dromedary camel herd, Saudi Arabia.","volume":"20","author":"Hemida","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R75","doi-asserted-by":"crossref","unstructured":"Farag EA, Reusken CB, Haagmans BL, Mohran KA, Raj V, Pas SD, High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol. 2015;5:28305. 26183160","DOI":"10.3402\/iee.v5.28305"},{"key":"key-10.3201\/eid2207.160022-201607140919-R76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1126\/science.aad1283","article-title":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels.","volume":"351","author":"Haagmans","year":"2016","journal-title":"Science"},{"key":"key-10.3201\/eid2207.160022-201607140919-R77","unstructured":"Food and Drug Administration. Guidances (Drugs) [cited 2015 Aug 11]. http:\/\/www.fda.gov\/Drugs\/GuidancecomplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"key-10.3201\/eid2207.160022-201607140919-R78","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia.","volume":"29","author":"Saad","year":"2014","journal-title":"Int J Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R79","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study.","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R80","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ajpath.2015.10.024","article-title":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in United Arab Emirates, April 2014.","volume":"186","author":"Ng","year":"2016","journal-title":"Am J Pathol"},{"key":"key-10.3201\/eid2207.160022-201607140919-R81","doi-asserted-by":"crossref","unstructured":"Chu H, Zhou J, Wong BHY, Li C, Chan JFW, Cheng ZS, Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis. 2016;904\u201314.http:10.1093\/infdis\/jiv380","DOI":"10.1093\/infdis\/jiv380"},{"key":"key-10.3201\/eid2207.160022-201607140919-R82","unstructured":"International Severe Acute Respiratory and Emerging Infection Consortium. Severe acute respiratory infection data tools [cited 2015 Aug 11]. https:\/\/isaric.tghn.org\/protocols\/severe-acute-respiratory-infection-data-tools\/"},{"key":"key-10.3201\/eid2207.160022-201607140919-R83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1473-3099(13)70327-X","article-title":"Open source clinical science for emerging infections.","volume":"14","author":"Dunning","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2207.160022-201607140919-R84","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. Updated 2 July 2015 [cited 2015 Aug 11]. http:\/\/apps.who.int\/iris\/bitstream\/10665\/178529\/1\/WHO_MERS_Clinical_15.1_eng.pdf"},{"key":"key-10.3201\/eid2207.160022-201607140919-R85","article-title":"Time course of MERS-CoV infection and immunity in dromedary camels","author":"Meyer","journal-title":"Emerg Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/22\/7\/16-0022_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:27:33Z","timestamp":1732922853000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/22\/7\/16-0022_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":85,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2207.160022","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}